Lundbeck poaches CSO from US biotech firm

Lundbeck has been on the prowl at US biotech company Immunitas Therapeutics, where it has found its new Head of Research with responsibility for drug discovery and early clinical development.

Future SVP and Head of Research at Lundbeck Tarek Samad | Photo: Lundbeck / PR

Lundbeck has now found the person who will be in charge of accelerating the Danish pharmaceutical company's drug discovery and early clinical development research.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs